Monogram Biosciences advances individualized medicine by developing and marketing innovative products to help guide and improve the treatment of infectious diseases and cancer. Our products are designed to help clinicians optimize treatment regimens for their patients leading to better outcomes and reduced costs. Our technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines.

Monogram Biosciences' HIV Products

Monogram Biosciences is the leading provider of HIV tests that help manage the complexities of antiretroviral therapy. PhenoSenseGT® (combination phenotype and genotype), PhenoSense®, GeneSeq®, PhenoSense Entry™ and PhenoSense Integrase, are intended to help healthcare providers choose the drugs that will provide the greatest benefits to individual patients. Our tropism test, Trofile™, is accurate, precise, sensitive, reproducible and robust in the measurement of HIV-1 co-receptor tropism. Trofile is clinically validated and has been used in phase II and III clinical trials to select patients for treatment with CCR5 antagonists. One such drug, Selzentry™, is available for clinical use and Trofile is clinically validated for selection of appropriate patients for Selzentry.

For our biopharmaceutical partners, Monogram provides the most accurate, advanced and comprehensive technologies for measuring viral characteristics – essential information for the development of new drugs and vaccines for infectious diseases.

- The Monogram Team, dedicated to the HIV community, because failure is not an option.